HHS Ends mRNA Vaccine Funding, Citing Safety Concerns

U.S. Health Secretary Robert F. Kennedy Jr. has cancelled nearly $500 million in federal funding for 22 mRNA vaccine development projects, citing claims that mRNA vaccines 'pose more risks than benefits' for respiratory viruses such as COVID-19 and influenza. The decision has been met with widespread condemnation from the scientific community, including Nobel laureate Katalin Karikó and multiple infectious disease experts, who argue that mRNA vaccines have saved millions of lives and are essential for future pandemic preparedness. Critics warn the move could drive top researchers and vaccine innovation to countries like China, potentially undermining U.S. national security and making the nation more vulnerable to pandemics or bioterrorism. Many experts also highlight the lack of transparency in the review process and maintain that Kennedy's rationale is not supported by the scientific consensus. Industry groups fear this policy shift could set back U.S. leadership in vaccine innovation, as mRNA technology has potential applications beyond COVID-19. The action reflects Kennedy's longstanding skepticism of vaccines and has been described by some as a dangerous public health decision.